- 全部删除
 
您的购物车当前为空
Bractoppin 是一种BRCA1 (t)BRCT domain 识别磷酸肽的选择性抑制剂,IC50为 74 nM。它优先抑制 BRCA1 -tBRCT 依赖的 DNA 损伤。它减少 BRCA1 对 DNA 断裂片段的招募,进而抑制损伤诱导的 G2 期阻滞和重组酶 RAD51 的组装。


为众多的药物研发团队赋能,
让新药发现更简单!
Bractoppin 是一种BRCA1 (t)BRCT domain 识别磷酸肽的选择性抑制剂,IC50为 74 nM。它优先抑制 BRCA1 -tBRCT 依赖的 DNA 损伤。它减少 BRCA1 对 DNA 断裂片段的招募,进而抑制损伤诱导的 G2 期阻滞和重组酶 RAD51 的组装。
| 规格 | 价格 | 库存 | 数量 | 
|---|---|---|---|
| 1 mg | ¥ 523  | In stock | |
| 2 mg | ¥ 743  | In stock | |
| 5 mg | ¥ 1,070  | In stock | |
| 10 mg | ¥ 1,720  | In stock | |
| 25 mg | ¥ 2,970  | In stock | |
| 50 mg | ¥ 4,650  | In stock | |
| 100 mg | ¥ 6,520  | In stock | |
| 500 mg | ¥ 12,800  | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 1,180  | In stock | 
Bractoppin 相关产品
| 产品描述 | Bractoppin is a drug-like inhibitor of phosphopeptide recognition by the human BRCA1 tandem (t)BRCT domain (IC50 = 0.074 μM), which selectively inhibits substrate binding with nanomolar potency in vitro. Structure-activity exploration suggests that Bractoppin engages BRCA1 tBRCT residues recognizing pSer in the consensus motif, pSer-Pro-Thr-Phe, plus an abutting hydrophobic pocket that is distinct in structurally related BRCT domains, conferring selectivity.  | 
| 分子量 | 414.47 | 
| 分子式 | C25H23FN4O | 
| CAS No. | 2290527-07-8 | 
| Smiles | Fc1ccccc1CN1CCN(CC1)C(=O)c1ccc2[nH]c(nc2c1)-c1ccccc1 | 
| 密度 | 1.299 g/cm3 (Predicted) | 
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 83.3 mg/mL (200.98 mM), Sonication and heating are recommended.   | |||||||||||||||||||||||||||||||||||
溶液配制表  | ||||||||||||||||||||||||||||||||||||
DMSO 
  | ||||||||||||||||||||||||||||||||||||
评论内容